SYROS PHARMACEUTICALS, INC. Current Assets
SYROS PHARMACEUTICALS, INC. had Current Assets of $63.93 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-10-31
- 2024-09-30: Assets, Current $63.93M.
- 2024-06-30: Assets, Current $84.92M.
- 2024-03-31: Assets, Current $112.20M.
- 2023-12-31: Assets, Current $144.98M.
| Period end | Assets, Current |
|---|---|
| 2024-09-30 | $63.93M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $84.92M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $112.20M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $144.98M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $122.52M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $152.63M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $173.64M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $211.39M 10-K · filed 2024-03-27 |
| 2022-09-30 | $252.31M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $91.94M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $116.48M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $136.59M 10-K · filed 2023-03-02 |
| 2021-09-30 | $153.27M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $186.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $226.68M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $178.56M 10-K · filed 2022-03-15 |
| 2020-09-30 | $98.56M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $112.45M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $125.69M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $114.51M 10-K · filed 2021-03-04 |
| 2019-09-30 | $111.02M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $124.37M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $77.76M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $101.73M 10-K · filed 2020-03-05 |
| 2018-09-30 | $115.54M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $126.95M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $123.37M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $73.16M 10-K · filed 2019-03-07 |
| 2017-09-30 | $83.17M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $93.19M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $72.50M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $85.51M 10-K · filed 2018-03-12 |
| 2016-09-30 | $94.88M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $52.15M 10-Q · filed 2016-08-15 |
| 2015-12-31 | $36.45M 10-K · filed 2017-03-20 |